Drugs & Drug Candidates Issues Research Articles in September 2024 Edition
November 01, 2024
November 01, 2024
BASEL, Switzerland, Nov. 1 -- Drugs and Drug Candidates, a peer-reviewed journal that says it covers all steps involved in therapeutic agent, published research articles on the following topics in its September 2024 edition (Vol. 3, Issue 3):
* Article - Enhanced Lung Cancer Therapy via Co-Encapsulation of Docetaxel and Betulinic Acid
* Article - Indazole-Quinolone Hybrids as Anti-Virulence Agents against Pseudomonas aeruginosa
* Article - Microwave and Rad . . .
* Article - Enhanced Lung Cancer Therapy via Co-Encapsulation of Docetaxel and Betulinic Acid
* Article - Indazole-Quinolone Hybrids as Anti-Virulence Agents against Pseudomonas aeruginosa
* Article - Microwave and Rad . . .